Needham hosted an expert to discuss potential impact of trade tariffs and personnel changes on healthcare equities. Generic ...

It’s bulking season for Mark Wahlberg. The Hollywood actor candidly shared his fitness journey with his 30.9 million followers on social media after he stripped down to nothing but his shorts.

A Mark Ronson performance didn’t go so well for him. The award-winning producer and artist shared on social media that he hurt himself during a recent DJ set. The “Uptown Funk” star posted a ...

Mark Ronson landed in the hospital after he pulled two bicep tendons during a recent DJ set. On Wednesday, the 49-year-old musician detailed how he got his injury, writing in an Instagram post ...

It’s no wonder owner Mark Davis said, “I say it every year, this is my favorite time: We are undefeated.” The Raiders have their third head coach and General Manager pairing in three years. It’s a big ...

Mark Cuban, who no longer owns the Mavericks, urged general manager Nico Harrison not to trade Doncic, according to NBA insider Marc Stein. However, by the time Harrison and Cuban connected ...

Apple is likely to take a multi-pronged approach to manage the impact of impending tariffs on its products, according to Bloomberg's Mark Gurman. The company faces looming challenges, as new ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage trial.

Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein ...

After years of delays Pfizer and Eli Lilly’s tanezumab non-opioid pain drug is edging closer to approval, after it met targets in an osteoarthritis trial. Tanezumab is a nerve growth factor (NGF ...

Let's consider two great examples: Eli Lilly (NYSE: LLY) and Veeva Systems (NYSE: VEEV). Here's what investors need to know about these market leaders that could deliver outsized returns in the ...